| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.75B | $5.27B | $4.08B |
| YoY Revenue Growth % | +9.1% | +29.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.25B | $1.02B | $1.03B |
| Operating Margin % | 21.7% | 19.3% | 25.2% |
| Net Income (GAAP) | $1.06B | $860.8M | $872.3M |
| EBITDA (Normalized) | $1.46B | $1.21B | $1.18B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.99B | $3.57B | $2.96B |
| Capital Expenditures (CapEx) | $258.7M | $237.2M | $183.6M |
| Free Cash Flow (FCF) | $3.74B | $3.34B | $2.78B |
| FCF Margin % | 65.0% | 63.3% | 68.0% |
| Return on Invested Capital (ROIC %) | 1.8% | 1.5% | 4.5% |
| Cash & Short-Term Equivalents | $434.8M | $445.0M | — |
| Total Debt (Short + Long Term) | $14.70B | $13.40B | $6.97B |
| Total Stockholders' Equity | $39.44B | $38.84B | $14.29B |